The calcium-sensing receptor and related diseases

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):628-39. doi: 10.1590/s0004-27302006000400008.


The calcium-sensing receptor (CASR) adjusts the extracellular calcium set point regulating PTH secretion and renal calcium excretion. The receptor is expressed in several tissues and is also involved in other cellular functions such as proliferation, differentiation and other hormonal secretion. High extracellular calcium levels activate the receptor resulting in modulation of several signaling pathways depending on the target tissues. Mutations in the CASR gene can result in gain or loss of receptor function. Gain of function mutations are associated to Autossomal dominant hypocalcemia and Bartter syndrome type V, while loss of function mutations are associated to Familial hypocalciuric hypercalcemia and Neonatal severe hyperparathyroidism. More than one hundred mutations were described in this gene. In addition to calcium, the receptor also interacts with several ions and polyamines. The CASR is a potential therapeutic target to treatment of diseases including hyperparathyroidism and osteoporosis, since its interaction with pharmacological compounds results in modulation of PTH secretion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium Metabolism Disorders / genetics*
  • Humans
  • Hypercalcemia / complications
  • Hypercalcemia / genetics
  • Hyperparathyroidism / complications
  • Hyperparathyroidism / genetics
  • Hypocalcemia / complications
  • Hypocalcemia / genetics
  • Hypoparathyroidism / complications
  • Hypoparathyroidism / genetics
  • Mutation / genetics*
  • Parathyroid Diseases / genetics*
  • Polymorphism, Genetic
  • Receptors, Calcium-Sensing / genetics*
  • Receptors, Calcium-Sensing / physiology


  • Receptors, Calcium-Sensing